Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Godman B, Shrank W, Wettermark B, Andersen M, Bishop I, Burkhardt T, Garuolienè K, Kalaba M, Laius O, Joppi R, Sermet C, Schwabe U, Teixeira I, Tulunay FC, Wendykowska K, Zara C, Gustafsson LL. Godman B, et al. Among authors: burkhardt t. Pharmaceuticals (Basel). 2010 Aug 5;3(8):2470-2494. doi: 10.3390/ph3082470. Pharmaceuticals (Basel). 2010. PMID: 27713363 Free PMC article. Review.
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.
Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, Garuoliene K, Herholz H, Joppi R, Kalaba M, Laius O, McGinn D, Samaluk V, Sermet C, Schwabe U, Teixeira I, Tilson L, Tulunay FC, Vlahović-Palčevski V, Wendykowska K, Wettermark B, Zara C, Gustafsson LL. Godman B, et al. Among authors: burkhardt t. Expert Rev Pharmacoecon Outcomes Res. 2010 Dec;10(6):707-22. doi: 10.1586/erp.10.72. Expert Rev Pharmacoecon Outcomes Res. 2010. PMID: 21155704
Policies to enhance prescribing efficiency in europe: findings and future implications.
Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, Garuoliene K, Herholz H, Joppi R, Kalaba M, Laius O, Lonsdale J, Malmström RE, Martikainen JE, Samaluk V, Sermet C, Schwabe U, Teixeira I, Tilson L, Tulunay FC, Vlahović-Palčevski V, Wendykowska K, Wettermark B, Zara C, Gustafsson LL. Godman B, et al. Among authors: burkhardt t. Front Pharmacol. 2011 Jan 7;1:141. doi: 10.3389/fphar.2010.00141. eCollection 2010. Front Pharmacol. 2011. PMID: 21833180 Free PMC article.
Impact of reimbursement changes on statin use among patients with diabetes in Austria.
Winkelmayer WC, Asslaber M, Bucsics A, Burkhardt T, Schautzer A, Wieninger P, Pogantsch M, Brookhart MA; Pharmacoeconomics Advisory Council of the Austrian Sickness Funds. Winkelmayer WC, et al. Among authors: burkhardt t. Wien Klin Wochenschr. 2010 Feb;122(3-4):89-94. doi: 10.1007/s00508-009-1292-6. Wien Klin Wochenschr. 2010. PMID: 20213375
Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria.
Winkelmayer WC, Stedman MR, Pogantsch M, Wieninger P, Bucsics A, Asslaber M, Bauer R, Burkhardt T, Schautzer A, Brookhart MA; Pharmacoeconomics Advisory Council of the Main Association of Austrian Sickness Funds. Winkelmayer WC, et al. Among authors: burkhardt t. Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):57-65. doi: 10.1002/pds.2059. Epub 2010 Nov 15. Pharmacoepidemiol Drug Saf. 2011. PMID: 21182153
163 results